GAD-7 (General Anxiety Disorder-7) Psychiatric Evaluation and Evidence-Based Rating Scale NRNP-6635 week 2 discussion

The Generalized Anxiety Disorder-7 scale, or GAD-7, is a brief self-report screening tool used to assess anxiety symptoms and monitor symptom severity over time. It includes seven questions focused on symptoms experienced during the past two weeks, with scores ranging from 0 to 21. Higher scores indicate greater anxiety severity, with the tool classifying symptoms as minimal, mild, moderate, or severe.

Three important components of the psychiatric interview are the therapeutic relationship, the history of present illness, and the safety/risk assessment. The therapeutic relationship is essential because psychiatric assessment depends on trust, openness, and the client’s willingness to discuss sensitive information. When clients feel respected and not judged, they are more likely to disclose anxiety symptoms, trauma exposure, substance use, depressive symptoms, or suicidal thoughts. This relationship also allows the provider to observe the client’s affect, behavior, speech, eye contact, and engagement during the interview.

A second important component is the history of present illness. This part of the interview explores the onset, duration, frequency, severity, triggers, associated symptoms, functional impairment, and previous treatment or coping strategies. For a client presenting with anxiety, this information helps the provider determine whether the symptoms are most consistent with generalized anxiety disorder, panic disorder, trauma-related anxiety, substance-induced anxiety, depression with anxious distress, or anxiety related to a medical condition. The GAD-7 can support this process by giving the provider a measurable symptom baseline and a structured way to evaluate anxiety severity (O’Connor et al., 2023).

PLACE YOUR ORDER HERE

A third important component is the safety and risk assessment. Even when anxiety is the main concern, the psychiatric interview should include assessment of suicidal ideation, self-harm, homicidal ideation, psychosis, substance use, impulsivity, protective factors, and access to lethal means. This is important because anxiety symptoms may occur with depression, trauma, substance use, and other psychiatric conditions that can increase risk. A complete safety assessment helps the provider determine whether the client can be managed outpatient or needs a higher level of care.

The GAD-7 has strong psychometric support as a screening and symptom-monitoring tool. Recent evidence supports its reliability, validity, and clinical usefulness. Villarreal-Zegarra et al. (2024) found that the GAD-7 demonstrated strong reliability and supported a one-factor structure in a large general population sample. López et al. (2025) also found that the GAD-7 was a valid and reliable instrument for assessing generalized anxiety symptoms across a large Latin American sample, which supports its usefulness across diverse populations. In addition, Park and Park (2025) found that the GAD-7 had acceptable diagnostic accuracy for screening anxiety disorders in their updated systematic review and meta-analysis. O’Connor et al. (2023) also reported that anxiety screening instruments, including the GAD-7, showed adequate accuracy for detecting generalized anxiety disorder in adults.

The GAD-7 is appropriate to use during the psychiatric interview when a client reports excessive worry, nervousness, restlessness, irritability, difficulty relaxing, fearfulness, poor sleep, or physical symptoms that may be anxiety-related. It can be used during the initial psychiatric evaluation to establish a baseline and during follow-up visits to measure response to psychotherapy, medication, or combined treatment. For example, a client beginning cognitive behavioral therapy for anxiety may complete the GAD-7 at intake and again after several sessions to evaluate whether symptoms are improving.

For the psychiatric nurse practitioner, the GAD-7 is helpful because it provides a standardized way to quantify anxiety symptoms, monitor progress, and guide treatment planning. However, it should not be used as the only basis for diagnosis. A high score suggests clinically significant anxiety symptoms, but the provider must still complete a full psychiatric interview, assess functional impairment, consider differential diagnoses, rule out medical or substance-related causes, and evaluate comorbid conditions. When used correctly, the GAD-7 strengthens psychiatric assessment by combining client self-report, evidence-based measurement, and clinical judgment.

References

López, N., Morales-Asencio, B., Ripoll-Córdoba, D., Coronado-López, J., Caldichoury, N., Quispe-Ayala, C., Salazar, D., Florez, Y., Flores-Poma, I., Castellanos, C., Herrera Pino, J., Quispe-Rodríguez, I., Cárdenas-Valverde, J., Alcos-Flores, K., Muñoz-Romero, E., Cantillo-Pacheco, K., Martínez-Sande, P., Camargo, L., Ocampo-Barba, N., … Gargiulo, P. A. (2025). Internal validity and reliability of the GAD-7 test in Latin America. Chronic Stress, 9. https://doi.org/10.1177/24705470251315260Links to an external site.

O’Connor, E. A., Henninger, M., Perdue, L. A., Coppola, E. L., Thomas, R. G., & Gaynes, B. N. (2023). Anxiety screening: Evidence report and systematic review for the US Preventive Services Task Force. JAMA, 329(24), 2164–2177. https://doi.org/10.1001/jama.2023.6369Links to an external site.

Park, S. H., & Park, S. K. (2025). An updated systematic review and meta-analysis of the predictive validity of the General Anxiety Disorder-7 and General Anxiety Disorder-2 in screening for anxiety disorders. Journal of Affective Disorders, 391, 119913. https://doi.org/10.1016/j.jad.2025.119913Links to an external site.

Villarreal-Zegarra, D., Paredes-Angeles, R., Mayo-Puchoc, N., Arenas-Minaya, E., Huarcaya-Victoria, J., & Copez-Lonzoy, A. (2024). Psychometric properties of the GAD-7: A cross-sectional study of the Peruvian general population. BMC Psychology, 12, Article 183. https://doi.org/10.1186/s40359-024-01688-8Links to an external site.

GAD-7 (General Anxiety Disorder-7) Psychiatric Evaluation and Evidence-Based Rating Scale NRNP-6635 week 2 discussion sample 2

The psychiatric interview utilizes information obtained to facilitate a criteria-based mental disorder diagnosis (Boland & Verduin, 2022). It is unarguably the core of clinical psychiatry as, without it, there could be no clinically sound diagnosis and, therefore, no successful treatment of psychopathology. Screening for conditions that often involve a lack of patient insight, the time required for the interview, and the information discussed make the psychiatric interview more challenging than other medical interviews (Hierlihy & Latus, 2025). All aspects of the interview, from start to finish, are important, as each section can uncover an element that helps guide diagnosis and treatment. One element that must be present for the interview to be successful is the practitioner’s ability to establish rapport with the patient.

According to Boland & Verduin (2022), rapport within the clinical setting is achieved when there is a “harmonious responsiveness of the physician to the patient and the patient to the physician” (p. 2). Sensitive topics are discussed during this time, and for the patient to feel secure enough to disclose accurate information, they must feel safe to do so (Boland & Verduin, 2022). The psychiatric interview will likely be the first major encounter with the provider and a crucial time for information gathering and, more importantly, setting the stage for the therapeutic relationship (Pashak & Heron, 2022). By establishing a good rapport with the patient, the provider can be confident that the goals of successful diagnosis and treatment are likely.  Without rapport, the information obtained during the interview may be inaccurate and/or not reflect the full scope of the problems the patient is experiencing. Establishing rapport must be the very first goal for the practitioner when initiating the interview.

Another important aspect of the psychiatric interview is the history of the patient’s present illness. This part of the interview lends insight into the patient’s status and can reveal useful information. According to Moldawsky (2020), “psychiatric diagnoses are largely dependent on the patient history” (p. 1). The history should aim to obtain a chronological description of how the patient’s symptoms evolved into the current episode experienced (Boland & Verduin, 2022). During this history-taking, it is imperative to note any changes that may have occurred during this same period (Boland & Verduin, 2022). This section of the interview allows the practitioner to determine the length of time that the symptoms have been present, any fluctuations in these symptoms, and the severity of the symptoms experienced (Boland & Verduin, 2022). All these aspects assist the provider in determining the acuity of the patient’s illness and in ensuring patient safety.

During this section of the interview, other helpful information is solicited. Exploring factors that alleviate or exacerbate the symptoms, determining what has made the patient seek help at this time, and any triggering factors; in addition, the setting in which the symptoms first began and continue, and any past treatment that has been attempted can all be obtained during the history taking portion (Boland & Verduin, 2022). The sheer amount of information elicited during this period displays how important this section of the interview is. Failure to be thorough during this part can lead to an inaccurate diagnosis, thus resulting in inaccurate treatment. Good treatment requires an in-depth patient history, making this aspect significant GAD-7 (General Anxiety Disorder-7) Psychiatric Evaluation and Evidence-Based Rating Scale NRNP-6635 week 2 discussion .

While it is difficult to select only certain aspects of the psychiatric interview that are important, the mental status examination is significant in that it is ultimately the PMHNP’s physical assessment of the patient (Voss & Das, 2024; Boland & Verduin, 2022). This section of the interview explores all aspects of mental functioning and indicates the presence of symptoms related to mental disorders (Boland & Verduin, 2022). Appearance, behavior, mood, speech, affect, motor activity, perceptual disturbances, cognition, thought content and processes, abstract reasoning, insight, and judgment all lend valuable information to the provider (Boland & Verduin, 2022). When this information is paired with other aspects of the interview, a wealth of information becomes available to make an accurate diagnosis. The mental status examination is important as it assists in identifying psychopathology, diagnosing, and monitoring symptoms of mental illness (Voss & Das, 2024).

Psychiatric rating scales are tools that can provide comprehensive information that supplements information obtained during an interview, as well as information that may not otherwise be discovered (Boland & Verduin, 2022). There are scales for many different disorders; often, multiple scales are available for the same disorder. One such tool is the Generalized Anxiety Disorder 7-Item Scale (GAD-7). This scale can be used in primary care settings, in addition to psychiatric settings, to screen for generalized anxiety disorder, as it has shown good performance and diagnostic accuracy in a variety of populations and settings (Villarreal-Zegarra et al., 2024).

According to Villarreal-Zegarra et al. (2024), anxiety disorders are considered one of the most debilitating mental illnesses and amongst the most common mental health ailments worldwide, with the prevalence on the rise. Based on this knowledge, it is imperative that all providers, and not just psychiatric providers, have access to tools that can assist in screening for these disorders. The ability to screen for anxiety disorders quickly and accurately avoids delays in patients receiving further evaluations and treatment. The GAD-7 is a rating instrument with the fewest number of items, is based on the Diagnostic and Statistical Manual for Mental Disorders, and has been widely researched, making it a reliable and valid tool that all clinicians can utilize (Villarreal-Zegarra et al., 2024).

The GAD-7 rating scale can be utilized by providers in many circumstances. The obvious resultant use would be if a patient is reporting possible symptoms of an anxiety disorder or if the patient voices concerns of a possible disorder. In addition, many medical diagnoses can have a comorbid anxiety disorder associated with them, such as epilepsy and chronic medical illnesses (Park & Park, 2025). This scale is particularly helpful to the PMHNP as it assists in quantifying the severity of symptoms, assists in guiding treatment approaches and adjustments, facilitates patient communication, improves clinical efficacy, and adheres to evidence-based practice guidelines.

References

Boland, R., & Verduin, M.L. (2022). Kaplan & Sadock’s synopsis of psychiatry (12^th ed). Wolters Kluwer.

Hierlihy, T., & Latus, A. (2025). An approach to teaching the psychiatric interview. BMC Medical Education, 25(1), 1-7. doi: 10.1186/s12909-024-06529-1

Moldawsky, R.J. (2020). Is the psychiatric history losing its relevance? The Permanente Journal, 24(19), 1-3. doi: 10.7812/TPP/19.186

Park, S.H., & Park, S.K. (2025). An updated systematic review and meta-analysis of the predictive validity of the general anxiety disorder (GAD)-7 and GAD-2 in screening for anxiety disorders. Journal of Affective Disorders, 391. doi: 10.1016/j.jad.2025.119913Links to an external site.

Pashak, T.J., & Heron, M.R. (2022). Build rapport and collect data: a teaching resource on the clinical interviewing intake. Discover Psychology, 2(20), doi: 10.1007/s44202-022-00019-5

Villarreal, D., Paredes-Angeles, R., Mayo-Puchoc, N., Arenas-Minaya, E., Huarcaya-Victoria, J., & Copez-Lonzoy, A. (2024). Psychometric Properties of the GAD-7 (Generalized Anxiety Disorder-7): a cross-sectional study of the Peruvian general population. BMC Psychology, 12(183), 1-8. doi:

Voss, R.M., & Das, J.M. (2024). Mental Status Examination. StatPearls. Retrieved from https://pubmed.ncbi.nlm.nih.gov/31536288/Links to an external site. GAD-7 (General Anxiety Disorder-7) Psychiatric Evaluation and Evidence-Based Rating Scale NRNP-6635 week 2 discussion